FSD Pharma Class Performance
| HUGEDelisted Stock | USD 0.09 0 4.56% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and FSD Pharma are completely uncorrelated. FSD Pharma Class now shows a risk of 0.0%. Please confirm FSD Pharma Class rate of daily change and period momentum indicator , to decide if FSD Pharma Class will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days FSD Pharma Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, FSD Pharma is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 17 M |
FSD |
FSD Pharma Relative Risk vs. Return Landscape
If you would invest 8.99 in FSD Pharma Class on September 3, 2024 and sell it today you would earn a total of 0.00 from holding FSD Pharma Class or generate 0.0% return on investment over 90 days. FSD Pharma Class is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than FSD, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
FSD Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for FSD Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as FSD Pharma Class, and traders can use it to determine the average amount a FSD Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HUGE |
Based on monthly moving average FSD Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FSD Pharma by adding FSD Pharma to a well-diversified portfolio.
FSD Pharma Fundamentals Growth
FSD Stock prices reflect investors' perceptions of the future prospects and financial health of FSD Pharma, and FSD Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on FSD Stock performance.
| Return On Equity | -0.64 | |||
| Return On Asset | -0.34 | |||
| Current Valuation | 4.57 M | |||
| Shares Outstanding | 46.06 M | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 91.86 X | |||
| EBITDA | (17.38 M) | |||
| Cash And Equivalents | 31.62 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 337.46 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 0.30 X | |||
| Cash Flow From Operations | (11.03 M) | |||
| Earnings Per Share | (0.25) X | |||
| Total Asset | 17.39 M | |||
| Retained Earnings | (157.1 M) | |||
| Current Asset | 3 M | |||
| Current Liabilities | 13 M | |||
About FSD Pharma Performance
By analyzing FSD Pharma's fundamental ratios, stakeholders can gain valuable insights into FSD Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if FSD Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if FSD Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.Things to note about FSD Pharma Class performance evaluation
Checking the ongoing alerts about FSD Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for FSD Pharma Class help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| FSD Pharma Class is now traded under the symbol QNTM. Please update your portfolios or report it if you believe this is an error. Report It! | |
| FSD Pharma Class is not yet fully synchronised with the market data | |
| FSD Pharma Class has some characteristics of a very speculative penny stock | |
| FSD Pharma Class has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (18.56 M) with loss before overhead, payroll, taxes, and interest of (3.33 M). | |
| FSD Pharma Class currently holds about 31.62 M in cash with (11.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing FSD Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether FSD Pharma's stock is overvalued or undervalued compared to its peers.
- Examining FSD Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating FSD Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of FSD Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of FSD Pharma's stock. These opinions can provide insight into FSD Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |